EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults

Mohsen Mazidi, Neil Wright, Pang Yao, Christiana Kartsonaki, Iona Y Millwood, Hannah Fry, Saredo Said, Alfred Pozarickij, Pei Pei, Yiping Chen, Baihan Wang, Daniel Avery und 16 weitere

European Journal of Epidemiology · 2024

DOI: 10.1007/s10654-024-01168-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Epidemiology, 2024. Verfasst von Mohsen Mazidi und 27 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK. Hauptthemen laut MEDLINE: Myocardial Ischemia, Proteomics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma proteomics could enhance risk prediction for multiple diseases beyond conventional risk factors or polygenic scores (PS). To assess utility of proteomics for risk prediction of ischemic heart disease (IHD) compared with conventional risk factors and PS in Chinese and European populations. A nested case-cohort study measured plasma levels of 2923 proteins using Olink Explore panel in ~ 4000 Chinese adults (1976 incident IHD cases and 2001 sub-cohort controls). We used conventional and machine learning (Boruta) methods to develop proteomics-based prediction models of IHD, with discrimination assessed using area under the curve (AUC), C-statistics and net reclassification index (NRI). These were compared with conventional risk factors and PS in Chinese and in 37,187 Europeans. Overall, 446 proteins were associated with IHD (false discovery rate < 0.05) in Chinese after adjustment for conventional cardiovascular disease risk factors. Proteomic risk models alone yielded higher C-statistics for IHD than conventional risk factors or PS (0.855 [95%CI 0.841–0.868] vs. 0.845 [0.829–0.860] vs 0.553 [0.528–0.578], respectively). Addition of 446 proteins to PS improved C-statistics to 0.857 (0.843–0.871) and NRI by 109.1%; and addition to conventional risk factors improved C-statistics to 0.868 (0.854–0.882) and NRI by 86.9%. Boruta analysis identified 30 proteins accounting for ~ 90% of improvement in NRI for IHD conferred by all 2923 proteins. Similar proteomic panels yielded comparable improvements in risk prediction of IHD in Europeans. Plasma proteomics improved risk prediction of IHD beyond conventional risk factors and PS and could enhance precision medicine approaches for primary prevention of IHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial IschemiaProteomicsAdultAgedFemaleHumansMaleMiddle AgedBiomarkersCase-Control StudiesChinaEast Asian PeopleEuropeRisk AssessmentRisk FactorsWhite PeopleGenetic Risk Score

Stichwörter der Autor:innen

Ischaemic heart diseaseMachine learningPlasma proteomicsPolygenic scoreProspective studiesRisk prediction

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
  • Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing, China.
  • Key Laboratory of Epidemiology of Major (Peking University), Ministry of Education, Beijing, China.
  • China National Center for Food Risk Assessment, Beijing, China.
  • Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK. robert.clarke@ndph.ox.ac.uk.

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Cancer Research UK
  • National Natural Science Foundation of China
  • GlaxoSmithKline and UK MRC
  • Key Research and Development Program of China
  • British Heart Foundation

Zitieren

APA

Mazidi, M., Wright, N., Yao, P., Kartsonaki, C., Millwood, I. Y., Fry, H., Said, S., Pozarickij, A., Pei, P., Chen, Y., Wang, B., Avery, D., Du, H., Schmidt, D. V., Yang, L., Lv, J., Yu, C., Sun, D., Chen, J., …, & China Kadoorie Biobank Collaborative Group (2024). Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults. European Journal of Epidemiology. https://doi.org/10.1007/s10654-024-01168-8

Vancouver

Mazidi M, Wright N, Yao P, Kartsonaki C, Millwood IY, Fry H, et al. Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults. European Journal of Epidemiology. 2024. doi:10.1007/s10654-024-01168-8

BibTeX
@article{Mazidi2024,
  author = {Mazidi, Mohsen and Wright, Neil and Yao, Pang and Kartsonaki, Christiana and Millwood, Iona Y and Fry, Hannah and Said, Saredo and Pozarickij, Alfred and Pei, Pei and Chen, Yiping and Wang, Baihan and Avery, Daniel and Du, Huaidong and Schmidt, Dan Valle and Yang, Ling and Lv, Jun and Yu, Canqing and Sun, DianJianYi and Chen, Junshi and Hill, Michael and Peto, Richard and Collins, Rory and Bennett, Derrick A and Walters, Robin G and Li, Liming and Clarke, Robert and Chen, Zhengming and China Kadoorie Biobank Collaborative Group, China Kadoorie Biobank Collaborative Group},
  title = {Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults},
  journal = {European Journal of Epidemiology},
  year = {2024},
  doi = {10.1007/s10654-024-01168-8}
}
Kostenlos starten →